Ad Astra Diagnostics
PrivateLast Round
Accelerator
Jan 14, 2025
Total Funding Raised
$20,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ad Astra Diagnostics operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was an Accelerator round in January 2025.
Ad Astra Diagnostics is a medical technology company that develops rapid point-of-care diagnostic systems for human health, including hematology analyzers for infection and sepsis detection.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ad Astra Diagnostics Comparables
Compare Ad Astra Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sight Diagnostics | 81% | |
| Soulbrain Holdings Co. Ltd | 81% | |
| Truvian | 78% |
For institutional investors. Book with your work email.
Ad Astra Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 14, 2025 | ||||
| Grant | Oct 24, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ad Astra Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| MATTER | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 46% MoM.
- Jan 6, 2026
Monthly visitors increased 53% MoM.
For institutional investors. Book with your work email.
Ad Astra Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ad Astra Diagnostics's valuation, stock price, and market status.
Is Ad Astra Diagnostics a public or private company?
Ad Astra Diagnostics is a private company.
What is the current stock price of Ad Astra Diagnostics?
Ad Astra Diagnostics is a private company, so its shares have no public market price. Caplight tracks Ad Astra Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ad Astra Diagnostics worth (valuation)?
Valuation information for Ad Astra Diagnostics is not publicly available.
Can I buy Ad Astra Diagnostics stock?
Ad Astra Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ad Astra Diagnostics's last funding round?
Ad Astra Diagnostics's most recent funding round was Accelerator on January 14, 2025.
Who are the main investors in Ad Astra Diagnostics?
Key investors in Ad Astra Diagnostics include Public Health Emergency Medical Countermeasures Enterprise, MATTER.
Will Ad Astra Diagnostics IPO soon?
No public IPO plans have been announced for Ad Astra Diagnostics.
How can I track Ad Astra Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Ad Astra Diagnostics's shares on secondary markets.